Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/06/2003CN1434711A Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat dna and rna viruses
08/06/2003CN1434710A Specific therapeutic composition for treating AIDS
08/06/2003CN1434709A Remedies for diseases due to stenotic lesions of blood vessel
08/06/2003CN1434708A Novel sertraline hydrochl oride polymorphs, processes for preparing them, compositions containing them and methods of using them
08/06/2003CN1434707A Method and compositions for preventing hormone induced adverse effects
08/06/2003CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose
08/06/2003CN1434702A Novel forms of pravastatin sodium
08/06/2003CN1434698A Hair growth stimulant compositions
08/06/2003CN1434691A Tissue sensitizing compounds for females and methods and apparatus for the delivery of these compounds
08/06/2003CN1434681A Method for maintaining on improving the synthesis of mucins
08/06/2003CN1434054A Dowble-stranded RNA and use thereof
08/06/2003CN1434053A Rhizoma anemarrhenae extract and preparation process and use thereof
08/06/2003CN1434052A Cranesbill total flavonoid extract and use in preparation of anti-virus medicine
08/06/2003CN1434047A Calcarisporin B1 and extracting method and use in anti-tumor medicine
08/06/2003CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434042A Cattail pollen extract and preparation process and use thereof
08/06/2003CN1434041A Anti-tumor medicine and use thereof
08/06/2003CN1434040A Medicine with 1,6-methylene-[10]-annulene difuran and steroid basic structure and use thereof
08/06/2003CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1433808A Compound prunella spike capsule and preparation process thereof
08/06/2003CN1433807A Compound psorolea tincture for treating leukoderma
08/06/2003CN1433796A Medicine for treating genital herpes and preparation process thereof
08/06/2003CN1433775A Long-ncting heparin intraocular slow-released system
08/06/2003CN1433774A Medicinal composition
08/06/2003CN1433773A Use of angelica polysacchavide and sodium ferulate composition in preparation of analgesic
08/06/2003CN1433772A Use of angelica polysaccharide in preparation of analgesic
08/06/2003CN1433771A Use of angelica polysaccharide and sodium ferulate composition in preparation of medicine for treating hepatic injury
08/06/2003CN1433770A Use of BCG polysaccharide and Nucleic acid preparation in preparation of medicine for oral cavity local medication
08/06/2003CN1433769A Boping capsule preparation for treating cardiovascular and cevebrovascnlar disease and preparation process thereof
08/06/2003CN1433768A Flavone Hippophaes slow-released, control-redeased agent
08/06/2003CN1433767A Active extracted composition of teasel root and notoginseng and use in medicine
08/06/2003CN1433766A Medicine for treating metabolism syndrome
08/06/2003CN1433765A Sodium foscarnet froozen dry preparation and process for preparing same
08/06/2003CN1433764A Sodium foscarnet gel preparation and preparation process thereof
08/06/2003CN1433763A Enoxacin preparation and preparation process thereof
08/06/2003CN1433762A New use of fluoroquinolone group medicine and berberine
08/06/2003CN1433761A Piperazine ferulate slow-released, control-released agent
08/06/2003CN1433760A Oral tablet containing 2-ÒÇö(4-methoxy-3-methyl)-2-pyridylÒÇòmethylsulfonyl-5-(1-H-pyrrole-1-group)-1H-benzimidazole
08/06/2003CN1433759A Slow-released composition of ondansetron gydrochloride
08/06/2003CN1433758A Use of potassium dehydroandrographolide succinate in preparing external used medicine
08/06/2003CN1433757A Use of potassium dehydroandrographolide succinate in preparing oral cavity local applied medicine for treating plaryngitis
08/06/2003CN1433756A Use of potassium dehydroandrographolide succinate in preparing external used medicine for treating dermatosis
08/06/2003CN1433755A Long-acting tretnoin intraocular slow-releasing system
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117098C Cancer suppressing action of antisense nucleic acid to leukemia gene of bursa-dependent lymphocyte
08/06/2003CN1117096C Oligo-Amorphophallus rivieri glucomajnnan glycan aldehydic acid propyl ester sodium sulfovindte and preparation and use thereof
08/06/2003CN1117095C Antibacterial substituted 7-2cylamino-3(methylhydrazono) methyl-cephalosponins and intermediates
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117089C Substituted 2(2,6-dioxopiperidin-3-yl)phthaliomides and -1-xoisoindolines and method of reducing TNF-alpha levels
08/06/2003CN1117085C Sparfloxacin salt and synthesis method and use thereof
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/06/2003CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1117075C Implementation of red shift using organic sulfur compound in ultraviolet/visible light absorption band of carotenoid
08/06/2003CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
08/06/2003CN1117068C Method for preparation of laminine
08/06/2003CN1117057C Cyclopentenones, process for preparing same, and use thereof
08/06/2003CN1116899C Oral pharmaceutical dosage forms comprising a proton pump inhibitorand NSAID
08/06/2003CN1116894C Medicine for treating cardiovascular disease
08/06/2003CN1116888C Medicine composition for treating woman's sexual function disease
08/06/2003CN1116886C Process for preparing Chinese-medicinal pills containing borneol
08/06/2003CN1116885C Medicine for treating piles
08/06/2003CN1116882C Chinese medicine composition for curing spur and hyperosteoeny and its preparing method
08/06/2003CN1116879C Process for preparing compound pancreatic ribonucleate for injection
08/06/2003CN1116878C Nutrient for prevention and treatment of fatty liver caused by drinking wine and its mfg. method
08/06/2003CN1116877C Carboprost methylate preparation able to be absorbed via oral musoca and its preparing process
08/06/2003CN1116876C Therapeutic anti-asthma agents containing selenium compounds
08/06/2003CN1116875C Taxual-lipid composition and its preparing process
08/06/2003CN1116874C TPA injection and its producing technology
08/06/2003CN1116873C Anti inflammatory analgesic medicine and prepn thereof
08/06/2003CN1116872C Medicament product
08/06/2003CN1116871C Pharmaceutical compositions and containing S-alkylisothiouronium derivatives
08/06/2003CN1116870C Applicatino of preventing and treating peripheral neurophathy by administering selegiline
08/06/2003CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness
08/05/2003US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
08/05/2003US6603041 Inhibit binding of integrins to their ligands and are of use in prophylaxis and therapy of of immune or inflammatory disorders, or disorders including inappropriate growth or migration of cells
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603023 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6603011 3-pyridinyl compounds
08/05/2003US6603009 Oxidation of a thioether to a sulfoxide using sodium percarbonate and a molybdenum salt as catalyst; making lansoprazole, omeprazole, rabeprazole, and pantoprazole
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6603006 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use
08/05/2003US6602999 Preparing a solution of cefpodoxime proxetil in a suitable solvent and recovering amorphous form of cefpodoxime proxetil from said solution by spray drying
08/05/2003US6602988 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects
08/05/2003US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers
08/05/2003US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
08/05/2003US6602912 Preferably administered along with a basic permeation enhancer and a hydroxide-releasing agent such as sodium hydroxide.
08/05/2003US6602911 Methods of treating fibromyalgia
08/05/2003US6602910 Treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine
08/05/2003US6602909 Selected essential amino acid supplementation of dietary proteins to lower urinary urea and peak glucose levels
08/05/2003US6602908 Suppression of carcinoma using high purity conjugated fatty acid
08/05/2003US6602906 Method for delivering ascorbic acid and acetone to the dermal layer of the skin
08/05/2003US6602905 N-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure
1 ... 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 5400 5401 5402 5403 5404 5405 5406 ... 7860